NOVOSTITCH™
-
Sports Medicine
Smith+Nephew’s NOVOSTITCH™ Meniscal Repair System shows 91.7% success rate in “STITCH” Study at one-year follow-up
LONDON, Oct. 9, 2019 /PRNewswire/ — Smith+Nephew (LSE:SN,NYSE:SNN), the global medical technology business, is pleased to announce results for its NOVOSTITCH Meniscal…
Read More » -
Recon
Smith & Nephew meniscal knee repair technology delivers 0% re-operation rate and 100% meniscal healing at six months shows first ever study of horizontal cleavage tears
LONDON, July 11, 2019 /PRNewswire/ — Smith & Nephew (NYSE: SNN; LSE: SN), the global medical technology business, today announces the results of…
Read More »